Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × ixabepilone × Other solid neoplasm × Clear all

Phase

Status

Completed 5 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Thoracic 1 Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

Cisplatin 7 Pemetrexed 6 atezolizumab 5 Carboplatin 4 Paclitaxel 3 Leucovorin 3 Filgrastim 3 Etoposide 3 vistusertib 2 tislelizumab 2 Vincristine 2 Topotecan 2 Temozolomide 2 Tegafur 2 Sorafenib 2 Irinotecan 2 Immunoenzyme Techniques 2 Gemcitabine 2 Docetaxel 2 Cyclophosphamide 2 zirconium-89-trastuzumab 1 vandetanib 1 toripalimab 1 temsirolimus 1 tanespimycin 1 talazoparib 1 soblidotin 1 selinexor 1 sargramostim 1 roniciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01170871 2014-05-21

Ixabepilone and Pemetrexed/Solid Tumors

University of Southern California

Phase 1 Withdrawn

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡